Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37850f5dd4e4d7ecc208a399b53b82d4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 |
filingDate |
2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7010454810302ee9e8387775fdb221d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4634b1ac4a3a059342106cbe28441ed1 |
publicationDate |
2015-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015030667-A1 |
titleOfInvention |
Compositions and methods for treating underactive bladder |
abstract |
Methods and compositions for treating underactive bladder and/or symptoms thereof are disclosed, wherein the composition including an effective amount of a therapeutic agent and a pharmaceutically acceptable lipid vehicle is locally administered to the bladder, thereby treating the underactive bladder and/or symptoms thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018050008-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357487-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019099711-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021502981-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111629723-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596139-B2 |
priorityDate |
2013-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |